Lilly Arthritis Drug Approved for Alopecia
June 2022
in “
C&EN global enterprise
”
TLDR The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.
Eli Lilly's rheumatoid arthritis drug, Olumiant (baricitinib), has been approved as the first systemic treatment for severe alopecia areata, an autoimmune condition causing hair loss. Olumiant is a daily pill and had also received emergency use authorization from the FDA in May for treating certain hospitalized COVID-19 patients.